These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 29901084)
1. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3. Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084 [TBL] [Abstract][Full Text] [Related]
2. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling. Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720 [TBL] [Abstract][Full Text] [Related]
3. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo. Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392 [TBL] [Abstract][Full Text] [Related]
4. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4. Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054 [TBL] [Abstract][Full Text] [Related]
5. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Feng Y; Ke C; Tang Q; Dong H; Zheng X; Lin W; Ke J; Huang J; Yeung SC; Zhang H Cell Death Dis; 2014 Feb; 5(2):e1088. PubMed ID: 24577086 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Gao S; Li S; Duan X; Gu Z; Ma Z; Yuan X; Feng X; Wang H Mol Carcinog; 2017 Oct; 56(10):2301-2316. PubMed ID: 28574599 [TBL] [Abstract][Full Text] [Related]
7. [Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma]. Huo YQ; Ruan X; DU XL; Shang L; Cai Y; Xu X; Wang MR; Zhang Y; Fu SB Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):579-84. PubMed ID: 24314214 [TBL] [Abstract][Full Text] [Related]
8. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192 [TBL] [Abstract][Full Text] [Related]
10. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway. Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520 [TBL] [Abstract][Full Text] [Related]
11. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest. Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693 [TBL] [Abstract][Full Text] [Related]
12. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma. Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480 [TBL] [Abstract][Full Text] [Related]
13. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171 [TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest. Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863 [TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo. Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517 [TBL] [Abstract][Full Text] [Related]
16. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3. Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101 [TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest. Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688 [TBL] [Abstract][Full Text] [Related]
18. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989 [TBL] [Abstract][Full Text] [Related]
19. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells. Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551 [TBL] [Abstract][Full Text] [Related]